FDA cleared the Durashield Device Kit from SurGenTec, LLC on Sep 17, 2026 under K252995, a traditional 510(k). The device falls under product code GZT, Retractor, Self-Retaining, For Neurosurgery, regulated at 21 CFR 882.4800 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Sep 18, 2025. The decision came 364 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

SurGenTec, LLC has 7 other decisions in the tracker over the last 12 months: K262581 (GraftGun Universal Graft Delivery System (GDS®)), K261381 (TiLink-L™ SI Joint Fusion System), K262121 (Ion-L Navigated Instruments), K261209 (Ion-L).